Accueil   Diary - News   All news THERANEXUS announes the publication of two scientific papers and a presentation at the EFIC

THERANEXUS announes the publication of two scientific papers and a presentation at the EFIC

 

Publication of two papers in "ASSAY and Drug Development Technologies" and the "British Journal of Clinical Pharmacology" respectively


A presentation on the mechanism of action of THN101 on neuropathic pain

 

Lyon, 3 September 2019 – Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction between neurons and glial cells, has announced the publication of two scientific papers, one focusing on the expansion of the proprietary library of glial cell modulators, and the other on the clinical pharmacological profile of THN102. Theranexus has also announced a presentation on the mechanism of action and efficacy in models of THN101 on neuropathic pain during the European Pain Federation conference (EFIC) on 3-7 September in Valencia, Spain.

 

Read the press release